1. Academic Validation
  2. Presence of Astrocytic S1R/5-HT1A Heterocomplex in the mPFC: A Putative Link to S1R Activation Mediated Faster Antidepressant-Like Effects

Presence of Astrocytic S1R/5-HT1A Heterocomplex in the mPFC: A Putative Link to S1R Activation Mediated Faster Antidepressant-Like Effects

  • Mol Neurobiol. 2025 Nov 24;63(1):163. doi: 10.1007/s12035-025-05568-z.
Peng Ren # 1 2 Jing-Ya Wang # 3 Meng-Jie Xu 4 Han Ni 1 Shuang Zhang 4 Chen-Xing Yue 1 De-Yi Yang 1 Yun-Feng Li 5
Affiliations

Affiliations

  • 1 Academy of Military Medical Sciences, 100850, Beijing, People's Republic of China.
  • 2 Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 250021, Jinan, Shandong, People's Republic of China.
  • 3 Academy of Military Medical Sciences, 100850, Beijing, People's Republic of China. [email protected].
  • 4 Beijing Institute of Basic Medical Sciences, 100850, Beijing, People's Republic of China.
  • 5 Academy of Military Medical Sciences, 100850, Beijing, People's Republic of China. [email protected].
  • # Contributed equally.
Abstract

In the brain, sigma non-opioid intracellular receptor 1/serotonin 1A receptor (S1R/5-HT1A) heterocomplexes are primarily localized within neuronal networks and play a key role in mediating the faster antidepressant-like effects induced by S1R activation. Existing evidence further suggests that astrocytes in medial prefrontal cortex (mPFC) contribute to these S1R-triggered, accelerated antidepressant responses. To address this, the current study employed neurochemical and in vivo fiber photometry approaches to examine whether S1R/5-HT1A heterocomplexes exist in astrocytes and modulate astrocytic structure and function, and their potential behavioral consequences. Behavioral analyses demonstrated that combined administration of S1R agonist SA4503 (1.0 mg/kg, i.p.) and 5-HT1A receptor agonist 8-OH-DPAT (0.3 mg/kg, i.p.) elicited faster antidepressant-like responses, whereas 8-OH-DPAT alone at the tested dosage lacked intrinsic antidepressant activity. Utilizing in situ proximity ligation assay integrated with immunohistochemical labeling for astrocytic markers, S1R/5-HT1A heterocomplexes were identified within astrocytes of the hippocampus and mPFC. Subacute treatment with either SA-4503 alone or in combination with 8-OH-DPAT resulted in a significant elevation of these heterocomplexes in GFAP/S100β-positive cells, alongside an increase in astrocytic density, particularly within the mPFC. Pharmacological interventions further revealed that co-activation of S1R and 5-HT1A induced an enhanced astrocytic CA2+ signaling, potentially counteracting the 5-HT1A-mediated suppression of astrocytic activity. Additionally, targeted knockdown of astrocytic S1R disrupted S1R/5-HT1A heterocomplex formation in the mPFC and induced a depressive-like phenotype in mice. These findings confirm the existence of astrocytic S1R/5-HT1A heterocomplexes in the mPFC and implicate this glial mechanism in the faster antidepressant effects facilitated by S1R activation.

Keywords

Astrocyte; Depression; S1R/5-HT1A heterocomplex; Sigma non-opioid intracellular receptor 1.

Figures
Products